Moreover, IFN-γ can inhibit tumor angiogenesis and reshape the TME to favor immune cell infiltration and function, thus synergistically enhancing the antitumor immune response (Gosselin et al., 1999). The gene discussed is IFNG; the disease is neoplasm.